助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[13]条 当前为第1条到13条
 

相关语句
chronic severe hepatitis
    Clinical study of bioartificial liver support system on chronic severe hepatitis at intermediate or late stage
    血液滤过透析联合血浆置换治疗中晚期慢性重型肝炎的临床研究
    Methods The serum IGF-Ⅰ levels in 73,57 and 30 patients with chronic hepatitis(CH), liver cirrhosis(LC) and chronic severe hepatitis(CSH) respectively, and 30 healthy controls were detected by enzyme linked immunosorbent assay (ELISA).
    方法 应用酶联免疫吸 附试验(ELISA)检测73例慢性肝炎(CH)、57例肝硬化(LC)和30例慢性重型肝炎(CSH)患者及30名对照组血 清中IGF Ⅰ水平。
    There were signficant differences in the levels of serum FN between acut hepatitis and severe chronic hepatitis、cirrhosis and chronic severe hepatitis (P<0.05,P<0.001,P <0.001);
    急性肝炎与重度慢性肝炎、肝硬化、慢性重型肝炎之间差异有显著性(P<0.05、P<0.001、P<0.001);
    Preventable nursing care for patients with upper gastrointestinal hemorrhage of chronic severe hepatitis
    慢性重型肝炎上消化道出血的预见性护理
    Nursing of one case of chronic severe hepatitis complicating subcutaneous hematoma
    慢性重型肝炎并发巨大皮下血肿患者的护理1例
    Nursing Care of Patients with Chronic Severe Hepatitis Treated by MARS
    分子吸附再循环系统治疗慢性重型肝炎病人的护理
    The prevalence of the microsome antibody in chronic active hepatitis (CAH), chronic severe hepatitis, chronic persistent hepatitis (CPH), chronic lobular hepatitis (CPH) and acute hepatitis was 19%, 2/4, 0.1/8 and 0 respectively.
    抗微粒体自身抗体主要在慢性活动型肝炎(CAH)、慢性重型肝炎及慢性小叶型肝炎(CLH)中检出,其中以CAH检出率最高(18.9%)。
    Methods All the patients were suffering from chronic severe hepatitis in this study. 42 cases served as treatment group and 33 cases served as control group.
    方法 本研究所有患者均为慢性重型肝炎患者,其中治疗组42例,中期18例,晚期24例;
    These results showed that treating with CHDF plus PE can effectively improve the prognosis of the patients with chronic severe hepatitis at the intermediate and late stages.
    0。 结果显示HDF联合PE治疗有效改善了中晚期慢性重型肝炎患者的预后。
    Conclusion On the base of treatment of medicine , CHDF plus PE have been proved safe and effective in treating the patients with chronic severe hepatitis at intermediate and late stage, and they can improve the survival rate of the patients.
    结论 在内科综合治疗的基础上CHDF联合PE治疗对中晚期慢性重型肝炎安全有效,能有效提高慢性重型肝炎患者的存活率。
    Objective To observe the adverse reactions in treating chronic severe hepatitis with plasma exchange,we studied the preventive steps.
    目的 :观察血浆置换治疗慢性重型肝炎时的不良反应 ,探讨防治措施。
    Conclusion Serum FN levels could reflect the degrees of liver damages to some extent; Determining serum FN is helpful for evaluating state of the illness,the prognosis of severe chronic hepatitis、cirrhosis and chronic severe hepatitis.
    结论血清FN水平在一定程度上能反映肝脏损伤的程度,检测血清FN对估计重度慢性肝炎、肝硬化、慢性重型肝炎患者病情、预后、转归均有一定意义。
    Objective To discuss the characteristics of the hypoglycemia in the course of the development of the chronic severe hepatitis. To prevent from and reduce the occurrence of Hypoglycemia,and promote the recover of liver function through a nursing intervention.
    目的探讨慢性重型肝炎疾病发展过程中低血糖反应的特点,通过护理有效干预,减少低血糖发生,促进肝功能恢复。
 

首页上一页1下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社